Patent Yard Sign in
Expired Canadian patentCanada

Systems and methods for screening pharmaceutical chemicals

CA 2497343 C · Owner: Wakatsuki, Tetsuro · Inventors: Elson, Elliot; Wakatsuki, Tetsuro; Mcconnaughey, William B.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method for obtaining a response of a tissue model system to an activator includes contacting a bio-artificial tissue model system with an activator and measuring cellular mechanical response thereto of at least one of contractile force and tissue stiffness. A method for obtaining a response of a tissue model system to an activator includes contacting a bio-artificial tissue model system with an activator and measuring cellular mechanical response thereto of at least one of contractile force and hysteresis.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 14, 2002 and granted April 2, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 14, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 14, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 14, 2002
GrantedApril 2, 2013
Term endedAugust 14, 2022
Patent numberCA 2497343 C
Classification (IPC)C12N5/00 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedAug 14, 2002Patent grantedApril 2, 2013Term endedAug 14, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.